Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies

That's like merging Deutsche Bank and Commerzbank. Guess 1-(-1) = 2

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Bristol-Myers takes $74 bln bet against the marketThere are good reasons to buy rival oncology giant Celgene. But cost cuts don’t cover the 54 pct premium and the target’s owners get the financial benefit. Bristol is hoping for luck in the courts and multiple regulatory approvals that Celgene’s shareholders were skeptical of.
مصدر: Breakingviews - 🏆 470. / 51 اقرأ أكثر »